← Back to Search

Thiwáhe Gluwáš'akapi for Substance Abuse Prevention

N/A
Waitlist Available
Led By Nancy R Whitesell, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years old
10-12 years old on the date of the first program session
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 16 years of age for youth; up to 30 years for adults
Awards & highlights
No Placebo-Only Group

Summary

This trial will test the effectiveness of an adapted Strengthening Families Program, called Thiwáhe Gluwáš'akapi, for delaying the onset of substance use and reducing suicide risk among young adolescents, as well as reducing substance abuse among adults.

Who is the study for?
This trial is for American Indian families on a Northern Plains reservation, specifically adults over 18 who have a parenting role and children aged 10-12 attending school on the reservation. Both must enroll together, with the adult being a parent, grandparent, guardian or household member.
What is being tested?
The study tests Thiwáhe Gluwáš'akapi (TG), an adapted substance use prevention program. It aims to delay substance use in adolescents and reduce suicide risk among youth. The program's influence on adult substance abuse will also be evaluated.
What are the potential side effects?
Since this intervention involves educational and community engagement rather than medical treatment, traditional side effects are not applicable. However, participants may experience emotional discomfort discussing sensitive topics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am between 10 and 12 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 16 years of age for youth; up to 30 years for adults
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 16 years of age for youth; up to 30 years for adults for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Alcohol initiation
Alcohol intoxication initiation
Chewing tobacco initiation
+42 more
Secondary study objectives
Antisocial behavior [youth only]
Association with deviant peers [youth only]
Awareness of Connectedness scale (adapted) [youth only]
+29 more
Other study objectives
Daily fruit and vegetable consumption
Daily sugary drink consumption
Daily water consumption
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Thiwáhe Gluwáš'akapiExperimental Treatment1 Intervention
Weeks 1-7: Weekly in-person 2.5 hour family sessions 30 minute family meal 1 hour separate youth and adult sessions 1 hour family session
Group II: Woyute WaśteActive Control1 Intervention
Respect for community and cultural values regarding research protocols precluded use of a randomized controlled design with a control group receiving no intervention, so we identified a cost-effective comparison condition program to offer value to study participants. A focus on healthy eating and exercise was of interest to community partners and not expected to directly confound the primary outcomes of the TG program (substance use and suicide risk). Week 1 in-person 2.5 hour family session 30 minute family meal 2 hour interactive family session (3 stations) Weeks 2-7: text messages with program content and questions

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,800 Previous Clinical Trials
2,821,380 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,578 Previous Clinical Trials
3,286,406 Total Patients Enrolled
Nancy R Whitesell, PhDPrincipal InvestigatorUniversity of Colorado - Anschutz Medical Campus
1 Previous Clinical Trials
449 Total Patients Enrolled

Media Library

Thiwáhe Gluwáš'akapi Clinical Trial Eligibility Overview. Trial Name: NCT04222556 — N/A
Self-Harm Research Study Groups: Thiwáhe Gluwáš'akapi, Woyute Waśte
Self-Harm Clinical Trial 2023: Thiwáhe Gluwáš'akapi Highlights & Side Effects. Trial Name: NCT04222556 — N/A
Thiwáhe Gluwáš'akapi 2023 Treatment Timeline for Medical Study. Trial Name: NCT04222556 — N/A
~28 spots leftby Feb 2025